Bryan L. Walser
Nessuna posizione attualmente
Provenienza dei contatti di primo grado di Bryan L. Walser
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
| Subsidiary | Pharmaceuticals: Major | 15 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Bryan L. Walser tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
Oscient Pharmaceuticals Corp.
 Oscient Pharmaceuticals Corp. Miscellaneous Commercial ServicesCommercial Services Oscient Pharmaceuticals Corp. is a biopharmaceutical company that sells and markets products to community-based primary care physicians through its primary care sales force in the United States. It markets two products namely, ANTARA fenofibrate capsules, a cardiovascular product and FACTIVE gemifloxacin mesylate tablets, a fluoroquinolone antibiotic. It also has late-stage antibiotic candidate, Ramoplanin for the treatment of clostridium difficile-associated disease. The company was founded on May 09, 1961 and is headquartered in Waltham, MA. | Miscellaneous Commercial Services | Director/Board Member | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| SEQUENOM, INC. | Medical Specialties | Director/Board Member | |
| ESPERION THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Jazz Pharmaceuticals, Inc.
 Jazz Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Jazz Pharmaceuticals, Inc. develops and markets pharmaceutical products. Its medical products include xyrem, erwinaze, vyxeos, and kidrolas. The company was founded by Bruce C. Cozadd in 2003 and is headquartered in Palo Alto, CA. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO Director/Board Member | |
DiObex, Inc.
 DiObex, Inc. Pharmaceuticals: MajorHealth Technology DiObex, Inc. develops therapies for metabolic disease treatment. Its products address the markets for the treatment of diabetes and its co-morbidities such as hypertension, dyslipidemia, and visceral adiposity. The company was founded in 2003 and is headquartered in San Francisco, CA. | Pharmaceuticals: Major | Director/Board Member | |
Tecan Genomics, Inc.
 Tecan Genomics, Inc. Electronic Equipment/InstrumentsElectronic Technology Tecan Genomics, Inc. provides genomics sample preparation solutions. It offers solutions which make biological samples accessible for genomic analysis. The firm has commercialized numerous proprietary DNA and RNA sample preparation products for use in research and diagnostic applications. The company was founded by Jan D'Alvise, James W. Larrick and Nurith Kurn in 2000 and is headquartered in San Carlos, CA. | Electronic Equipment/Instruments | Director/Board Member | |
Sandoz, Inc.
 Sandoz, Inc. Pharmaceuticals: MajorHealth Technology Sandoz, Inc. develops, manufactures and distributes generic pharmaceutical products. The firm focuses on therapeutic drug categories such as anti-infective, central nervous system disorder treatments, cardiovascular medicines, gastrointestinal agent, oncology therapies, and respiratory therapies. The company was founded in 1946 and is headquartered in Princeton, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| CODEXIS, INC. | Chemicals: Specialty | Chief Executive Officer Director/Board Member | |
MAP Pharmaceuticals LLC
 MAP Pharmaceuticals LLC Medical SpecialtiesHealth Technology MAP Pharmaceuticals, Inc. develops therapies and inhalation delivery technologies. The company was founded by Thomas A. Armer on July 3, 2003 and is headquartered in Irvine, CA. | Medical Specialties | Director/Board Member | |
Paul Capital Advisors LLC
 Paul Capital Advisors LLC Financial ConglomeratesFinance Part of Paul Capital Partners LP, Paul Capital Advisors LLC provides investment services. The company is based in San Francisco, CA. | Financial Conglomerates | Corporate Officer/Principal | |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| The Trustees of Columbia University in The City of New York | College/University | Doctorate Degree | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree Doctorate Degree | |
| Stanford University | College/University | Undergraduate Degree | |
FirstMark Capital LLC
 FirstMark Capital LLC Investment ManagersFinance FirstMark Capital LLC (FirstMark Capital) is venture capital firm founded by Rick Heitzmann and Amish Jani in 1996. The firm is headquartered in New York. | Investment Managers | President | |
| Yale University | College/University | Corporate Officer/Principal Graduate Degree | |
| Tufts University | College/University | Corporate Officer/Principal | |
| Washington & Jefferson College | College/University | Undergraduate Degree | |
Prospect Venture Partners
 Prospect Venture Partners Investment ManagersFinance Prospect Venture Partners (Prospect Venture Partners) is a venture capital firm founded in 1997 by Alexander E. Barkas and David Schnell. The firm is headquartered in Palo Alto, California. | Investment Managers | Private Equity Investor | |
The Mount Sinai Hospital
 The Mount Sinai Hospital Hospital/Nursing ManagementHealth Services The Mount Sinai Hospital provides medical and healthcare services. The company was founded in 1952 and is headquartered in New York, NY. | Hospital/Nursing Management | Corporate Officer/Principal | |
| Icahn School of Medicine at Mount Sinai | College/University | Corporate Officer/Principal | |
| Walter Reed Army Medical Center | Corporate Officer/Principal | ||
Lemo USA, Inc.
 Lemo USA, Inc. Electronic ComponentsElectronic Technology Lemo USA, Inc. designs and manufactures custom connectors. It offers low voltage connectors, plastic and miniature connectors, high pressure and high voltage connectors, media converter, and cable assemblies. The company is headquartered in Rohnert Park, CA. | Electronic Components | Director/Board Member | |
| Walter Reed Army Institute of Research | Corporate Officer/Principal | ||
| JAZZ PHARMACEUTICALS PLC | Pharmaceuticals: Major | Director of Finance/CFO Director/Board Member | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
| Tufts University School of Medicine | College/University | Corporate Officer/Principal | |
| Griffintown Capital Partners LLC | Chairman | ||
| OSE Pharmaceuticals | Director/Board Member | ||
| OSE IMMUNOTHERAPEUTICS | Pharmaceuticals: Major | Director/Board Member | |
| Hudson Opera House | Director/Board Member | ||
| Hudson Hall | Director/Board Member | ||
| Norphan Pharmaceuticals, Inc. | Chairman | ||
| Allergan Research Corp. | Director/Board Member | ||
| MINK THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
Rivus Pharmaceuticals, Inc.
 Rivus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Rivus Pharmaceuticals, Inc. is a company dedicated to improving metabolic health by advancing a new class of medicines called controlled metabolic accelerators (CMAs). The company is based in Charlottesville, VA. Jayson Donald Alexander Dallas has been the CEO of the company since 2021. The company is a leader in mitochondrial biology and is developing a new class of medicines to address a primary driver of cardio-metabolic disease: obesity. Rivus' lead CMA is the investigational small molecule HU6 in development to treat obesity and associated metabolic diseases, including heart failure with preserved ejection fraction (HFpEF), metabolic dysfunction-associated steatotic liver disease (MASLD)/metabolic dysfunction-associated steatohepatitis (MASH), and type 2 diabetes. | Pharmaceuticals: Major | Director/Board Member | |
Pequot Capital Corp.
 Pequot Capital Corp. Investment ManagersFinance Pequot Capital Corp. provides investment advisory services. | Investment Managers | Private Equity Investor | |
Endeavor BioMedicines, Inc
 Endeavor BioMedicines, Inc Miscellaneous Commercial ServicesCommercial Services Endeavor BioMedicines, Inc is a clinical stage company located in Solana Beach, CA, that develops novel therapies for fibrosis and oncology. The company's lead program, env-101, is a hedgehog signalling inhibitor currently in phase 2 studies treating IPF, a progressive interstitial lung disease that causes inflammation and scarring in the lung. The company's second program is a HER3-targeted ADC that will begin clinical development in 2024 for the treatment of multiple solid tumors. The company's mission is to develop transformative medicines by targeting the underlying genetic and cellular causes of disease with best in class agents. Endeavor is partnered with XCures and is currently looking at the LOF mutation. Regardless of eligibility for the Endeavor trial, XCures will still send a list of other treatment options that could work for the cancer mutation. The company was founded by Miguel A. de los Ríos and John Hood, with John Hood serving as the CEO since incorporation. | Miscellaneous Commercial Services | Director/Board Member | |
Opna Immuno-Oncology SA
 Opna Immuno-Oncology SA BiotechnologyHealth Technology Opna Immuno-Oncology SA is a Swiss biotechnology company that focuses on researching and developing biotechnology products. The private company is based in Saint-Sulpice, Switzerland. | Biotechnology | Director/Board Member |
Statistiche
Distribuzione geografica
| Stati Uniti | 44 |
| Irlanda | 3 |
| Francia | 3 |
| Canada | 2 |
| Belgio | 2 |
Settori
| Health Technology | 20 |
| Consumer Services | 11 |
| Finance | 6 |
| Commercial Services | 4 |
| Electronic Technology | 3 |
Posizioni
| Director/Board Member | 171 |
| Corporate Officer/Principal | 46 |
| Independent Dir/Board Member | 40 |
| Chief Executive Officer | 21 |
| Chairman | 19 |
Contatti più connessi
| Insiders | |
|---|---|
| James Tananbaum | 60 |
| Patrick Enright | 41 |
| Mark McDade | 35 |
| Kathryn Falberg | 30 |
| Walter Flamenbaum | 26 |
| Mark Iwicki | 26 |
| Stacey Seltzer | 21 |
| Stephen Dilly | 15 |
| Mary M. Rozenman | 8 |
| Howard V. Raff | 8 |
| Rodney Young | 7 |
| Joon Yun | 5 |
| Mike Holfinger | 5 |
| Warren L. DeSouza | 5 |
| Robert Myles Elfont | 3 |
- Borsa valori
- Insiders
- Bryan L. Walser
- Connessioni Società
